1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Rimegepant Plus Glofitamab and CD19 CAR-T Therapy in R/R LBCLDisease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RecurrenceNot yet recruitingPhase 22026-05-29NCT07613788